1887

Abstract

The different pathotypes of can produce a large number of human diseases. Surveillance is complex since their differentiation is not easy. In particular, the detection of Shiga toxin-producing (STEC) serotype O157 : H7 consists of stool culture of a diarrhoeal sample on enriched and/or selective media and identification of presumptive colonies and confirmation, which require a certain level of training and are time-consuming and expensive.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a quick and easy way to obtain the protein spectrum of a microorganism, identify the genus and species, and detect potential biomarker peaks of certain characteristics.

To verify the usefulness of MALDI-TOF MS to rapidly identify and differentiate STEC O157 : H7 from other pathotypes.

The direct method was employed, and the information obtained using Microflex LT platform-based analysis from 60 clinical isolates (training set) was used to detect differences between the peptide fingerprints of STEC O157 : H7 and other strains. The protein profiles detected laid the foundations for the development and evaluation of machine learning predictive models in this study.

The detection of potential biomarkers in combination with machine learning predictive models in a new set of 142 samples, called ‘test set‘, achieved 99.3 % (141/142) correct classification, allowing us to distinguish between the isolates of STEC O157 : H7 and the other group. Great similarity was also observed with respect to this last group and the species when applying the potential biomarkers algorithm, allowing differentiation from STEC O157 : H7

Given that STEC O157 : H7 is the main causal agent of haemolytic uremic syndrome, and based on the performance values obtained in the present study (sensitivity=98.5 % and specificity=100.0 %), the implementation of this technique provides a proof of principle for MALDI-TOF MS and machine learning to identify biomarkers to rapidly screen or confirm STEC O157 : H7 versus other diarrhoeagenic in the future.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001675
2023-05-02
2024-12-09
Loading full text...

Full text loading...

References

  1. Cybulski RJ, Bateman AC, Bourassa L, Bryan A, Beail B et al. Clinical impact of a multiplex gastrointestinal polymerase chain reaction panel in patients with acute gastroenteritis. Clin Infect Dis 2018; 67:1688–1696 [View Article]
    [Google Scholar]
  2. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26:822–880 [View Article]
    [Google Scholar]
  3. Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH et al. The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 2012; 55 Suppl 4:S232–45 [View Article]
    [Google Scholar]
  4. Fleckenstein JM, Matthew Kuhlmann F, Sheikh A. Acute bacterial gastroenteritis. Gastroenterol Clin North Am 2021; 50:283–304 [View Article]
    [Google Scholar]
  5. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123–140 [View Article]
    [Google Scholar]
  6. Rivas M, Chinen I, Miliwebsky E, Masana M. Risk factors for Shiga toxin-producing Escherichia coli-associated human diseases. Microbiol Spectr 2014; 2: [View Article]
    [Google Scholar]
  7. FAO & WHO Shiga toxin-producing Escherichia coli (STEC) and food: attribution, characterization, and monitoring. Microbiological Risk Assessment Series No. 31. Rome, FAO: 2018 www.fao.org/3/ca0032en/ca0032en.pdf
  8. Ministerio de Salud ARGENTINA Boletín Integrado de Vigilancia. Vigilancia de Síndrome Urémico Hemolítico (SUH). In Informe ESPECIAL: Resultados DE STEC Del Laboratorio DE Referencia Nacional. Años 2016 A 2020. BIV 560 | SE 30 pp 59–68
    [Google Scholar]
  9. Pianciola L, Chinen I, Mazzeo M, Miliwebsky E, González G et al. Genotypic characterization of Escherichia coli O157:H7 strains that cause diarrhea and hemolytic uremic syndrome in Neuquén, Argentina. Int J Med Microbiol 2014; 304:499–504 [View Article]
    [Google Scholar]
  10. Pianciola L, D’Astek BA, Mazzeo M, Chinen I, Masana M et al. Genetic features of human and bovine Escherichia coli O157:H7 strains isolated in Argentina. Int J Med Microbiol 2016; 306:123–130 [View Article]
    [Google Scholar]
  11. Miliwebsky E, Deza NL, Zolezzi G, Baschkier A, Carbonari C et al. Manual de procedimientos Escherichia coli productor de toxina Shiga en el marco de la detección de E. coli diarreigénico; 2019 http://sgc.anlis.gob.ar/handle/123456789/2307
  12. Kallow W, Erhard M, Shah HN, Raptakis E, Welker M. MALDI-TOF MS for Microbial Identification: Years of Experimental Development to an Established Protocol. In Shah HN, Gharbia SE. eds Mass Spectrometry for Microbial Proteomics 2010 https://doi.org/10.1002/9780470665497.ch12
    [Google Scholar]
  13. He Y, Li H, Lu X, Stratton CW, Tang YW. Mass spectrometry biotyper system identifies enteric bacterial pathogens directly from colonies grown on selective stool culture media. J Clin Microbiol 2010; 48:3888–3892 [View Article] [PubMed]
    [Google Scholar]
  14. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 2010; 48:1169–1175 [View Article] [PubMed]
    [Google Scholar]
  15. Rocca MF, Zintgraff JC, Dattero ME, Santos LS, Ledesma M et al. A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs. J Virol Methods 2020; 286:113991 [View Article]
    [Google Scholar]
  16. Tran A, Alby K, Kerr A, Jones M, Gilligan PH. Cost savings realized by implementation of routine microbiological identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2015; 53:2473–2479 [View Article]
    [Google Scholar]
  17. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 2011; 49:1614–1616 [View Article] [PubMed]
    [Google Scholar]
  18. Lévesque S, Dufresne PJ, Soualhine H, Domingo MC, Bekal S et al. A side by side comparison of Bruker biotyper and VITEK MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory. PLoS One 2015; 10:e0144878 [View Article]
    [Google Scholar]
  19. Lee TF, Lee H, Chen CM, Du SH, Cheng YC et al. Comparison of the accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry with that of other commercial identification systems for identifying Staphylococcus saprophyticus in urine. J Clin Microbiol 2013; 51:1563–1566 [View Article]
    [Google Scholar]
  20. Oviaño M, Rodríguez-Sánchez B, Gómara M, Alcalá L, Zvezdanova E et al. Direct identification of clinical pathogens from liquid culture media by MALDI-TOF MS analysis. Clin Microbiol Infect 2018; 24:624–629 [View Article] [PubMed]
    [Google Scholar]
  21. Alejandro D-S, Luis D-C, Raquel G-B, Alejandra L-A. Fish, Tilapia, and Shigellosis: a review. Afr J Agric Res 2021; 17:498–512 [View Article]
    [Google Scholar]
  22. Bruker Daltonik GmbH, 2011 ClinPro Tools User Manual Version 3.0. Bremen: BrukerDaltonik GmbH; n.d
  23. Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect 2012; 18:1097–1103 [View Article]
    [Google Scholar]
  24. Camoez M, Sierra JM, Dominguez MA, Ferrer-Navarro M, Vila J et al. Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry. Clin Microbiol Infect 2016; 22:161 [View Article]
    [Google Scholar]
  25. Karcher D, Grenfell RC, Moreno AM, Moreno LZ, Vasconcellos SA et al. Identification of pathogenic and nonpathogenic Leptospira species of Brazilian isolates by matrix assisted laser desorption/ionization and time flight mass spectrometry [online]. Braz J Microbiol 2018; 49:900–908 [View Article]
    [Google Scholar]
  26. Wang HY, Lien F, Liu TP, Chen CH, Chen CJ et al. Application of a MALDI-TOF analysis platform (ClinProTools) for rapid and preliminary report of MRSA sequence types in Taiwan. PeerJ 2018; 6:e5784 [View Article] [PubMed]
    [Google Scholar]
  27. Stephens MA. EDF statistics for goodness of fit and some comparisons. JASA 1974; 69:730–737 [View Article]
    [Google Scholar]
  28. Wayne PA. Clinical and Laboratory Standard Institute;2008CLSI. In User Protocol for Evaluation of Qualitative Test Performance, Approved Guideline-Second Edition. CLSI document EP12-A2;
    [Google Scholar]
  29. Kubo Y, Ueda O, Nagamitsu S, Yamanishi H, Nakamura A et al. Novel strategy of rapid typing of Shiga toxin-producing Escherichia coli using MALDI biotyper and ClinProTools analysis. J Infect Chemother 2021; 27:1137–1142 [View Article] [PubMed]
    [Google Scholar]
  30. Mazzeo MF, Sorrentino A, Gaita M, Cacace G, Di Stasio M et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the discrimination of food-borne microorganisms. Appl Environ Microbiol 2006; 72:1180–1189 [View Article] [PubMed]
    [Google Scholar]
  31. Fagerquist CK, Garbus BR, Miller WG, Williams KE, Yee E et al. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics. Anal Chem 2010; 82:2717–2725 [View Article] [PubMed]
    [Google Scholar]
  32. Ojima-Kato T, Yamamoto N, Suzuki M, Fukunaga T, Tamura H. Discrimination of Escherichia coli O157, O26 and O111 from other serovars by MALDI-TOF MS based on the S10-GERMS method. PLoS One 2014; 9:e113458 [View Article] [PubMed]
    [Google Scholar]
  33. Clark CG, Kruczkiewicz P, Guan C, McCorrister SJ, Chong P et al. Evaluation of MALDI-TOF mass spectroscopy methods for determination of Escherichia coli pathotypes. J Microbiol Methods 2013; 94:180–191 [View Article] [PubMed]
    [Google Scholar]
  34. Ochoa ML, Harrington PB. Immunomagnetic isolation of enterohemorrhagic Escherichia coli O157:H7 from ground beef and identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and database searches. Anal Chem 2005; 77:5258–5267 [View Article] [PubMed]
    [Google Scholar]
  35. Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB et al. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?. PLoS One 2007; 2:e1024 [View Article] [PubMed]
    [Google Scholar]
  36. Friedrich AW, Zhang W, Bielaszewska M, Mellmann A, Köck R et al. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 2007; 45:39–45 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001675
Loading
/content/journal/jmm/10.1099/jmm.0.001675
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error